ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
CCDC41 Drives Oocyte Meiotic Progression by Promoting Rab11a/Rab7-Positive Vesicle Fusion with Target Membranes.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- CCDC41 Drives Oocyte Meiotic Progression by Promoting Rab11a/Rab7-Positive Vesicle Fusion with Target Membranes.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Coiled-coil domain-containing protein 41 (CCDC41), a core component of centriolar distal appendages involved in centriole assembly and ciliary vesicle docking, has remained functionally uncharacterized in oocyte meiosis. Here, it is demonstrated that CCDC41 is a versatile player in three key steps of oocyte meiosis. First, CCDC41 depletion significantly impaired meiotic resumption, a defect mechanistically linked to reduced Cyclin B1 accumulation, compromised cyclin-dependent kinase 1 (CDK1) activation, and dysregulation of the anaphase-promoting complex/cyclosome (APC/C) co-activators Cdc20 homolog 1 (CDH1) and cell division cycle 20 (CDC20). Notably, this arrest is rescued by pharmacological inhibition of CDC20. Second, CCDC41 knockdown disrupted spindle cortical migration, a defect ascribed to impaired fusion of RAS oncogene family (Rab11a)-positive vesicles with the plasma membrane, which in turn prevented the anchoring of cytoplasmic F-actin to the cortex. Third, CCDC41 depletion accelerated anaphase onset by prematurely silencing the spindle assembly checkpoint and enhancing CDC20-mediated Cyclin B1 degradation. Mechanistically, CCDC41 localizes to lysosomes, and its loss delays RAS oncogene family member 7 (Rab7)-positive late endosome fusion with these organelles, causing cytoplasmic dispersion of active cathepsin. Critically, pharmacological or genetic inhibition of cathepsin B restored meiotic progression in CCDC41-deficient oocytes. Collectively, the findings establish that CCDC41 is essential for faithful meiotic completion, it regulates CDC20 activity through promoting cathepsin delivery to lysosomes, and ensures proper spindle migration via Rab11a-dependent F-actin anchoring.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.